World Kidney Day 2010: Medical Aspects of 10 Live-Donor Renal Transplantations in a Single Center From a Developing Country
Abstract Background World Kidney Day (WKD) has become the most widely celebrated event associated with kidney disease in the world and the most successful effort to raise awareness among both the general public and government health officials about the dangers of kidney disease. We celebrated WKD 20...
Gespeichert in:
Veröffentlicht in: | Transplantation proceedings 2012, Vol.44 (1), p.47-48 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 48 |
---|---|
container_issue | 1 |
container_start_page | 47 |
container_title | Transplantation proceedings |
container_volume | 44 |
creator | Shah, P.R Modi, P.R Kute, V.B Vanikar, A.V Patel, H.V Gumber, M.R Shah, V.R Trivedi, H.L |
description | Abstract Background World Kidney Day (WKD) has become the most widely celebrated event associated with kidney disease in the world and the most successful effort to raise awareness among both the general public and government health officials about the dangers of kidney disease. We celebrated WKD 2010 in a unique way by performing 10 live-donor renal transplantations (RTx) on March 11, 2010. Patients and Methods We report a single-center experience on RTx vis-à-vis patient/graft survival, graft function in terms of serum creatinine (SCr) level, and rejection episodes in 10 live-donor RTx performed on WKD. Recipient diseases leading to end-stage renal disease (ESRD) were chronic glomerulonephritis (60%), benign nephrosclerosis (20%), and chronic interstitial nephritis (20%). Mean recipient age was 35 ± 8.7 years. Nine recipients were males. Mean donor age was 37 ± 8.7 years, Nine donors were females. Donors were spouse (n = 6), mother (n = 2), sister (n = 1), and extended family member (n = 1), with mean HLA match 1.8 ± 1.48. All patients received steroids, calcinueurin inhibitors, and mycophenolate mofetil/azathioprime for maintenance immunosuppression. Results During a mean follow-up time of 18 months, patient and graft survival rates were 90% and 90%, respectively, with a mean SCr level of 1.21 mg/dL; 20% had biopsy-proven acute rejection. One patient died due to infection after antirejection therapy. Conclusion RTx has acceptable graft and patient survival. RTx is the best cost-effective therapeutic modality for patients suffering from ESRD and should be encouraged in view of organ shortage on events such as WKD. To our knowledge, this is the first report from a developing country on 10 successful RTx on WKD. |
doi_str_mv | 10.1016/j.transproceed.2011.11.029 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_920366378</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0041134511016265</els_id><sourcerecordid>920366378</sourcerecordid><originalsourceid>FETCH-LOGICAL-c464t-d11c72a135a75f1d0a620c8a59d928e68ab153e791edaed165726ade4f3aef363</originalsourceid><addsrcrecordid>eNqNklGLEzEQxxdRvHr6FSQI4tPWTLKb3b0H4Wg9FSuCd-JjyCWzkrpNesm2UPzyztoeik_CQEjmP_8Mv5mieAF8DhzU6_V8TCbkbYoW0c0FB5hTcNE9KGbQNrIUSsiHxYzzCkqQVX1WPMl5zekuKvm4OBNCAq-belb8_BbT4NhH7wIe2NIcGNnxC_YJnbdmYJd5i3bMLPYMOFv5PZbLGGJiXzBQ-uZ3I4MJoxl9DJn5wAy79uH7gGyBYcTErlLc0OMS9zjELaXYIu7CmA5Pi0e9GTI-O53nxdertzeL9-Xq87sPi8tVaStVjaUDsI0wIGvT1D04bpTgtjV15zrRomrNLdQSmw7QGXSg6kYo47DqpcFeKnlevDr6ErG7HeZRb3y2OFDbGHdZd4JLpWTTkvLiqLQp5pyw19vkNyYdNHA9sddr_Td7PbHXFMSeip-fvtndbih3X3oPmwQvTwKTiW1PRtbnP7q6g65VQLrlUYcEZe8x6Ww9BksjSTQM7aL_v37e_GNjBx-mqf7AA-Z13CUaYdags9BcX0_bMi0LTMZC1fIXgP69Rg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>920366378</pqid></control><display><type>article</type><title>World Kidney Day 2010: Medical Aspects of 10 Live-Donor Renal Transplantations in a Single Center From a Developing Country</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Shah, P.R ; Modi, P.R ; Kute, V.B ; Vanikar, A.V ; Patel, H.V ; Gumber, M.R ; Shah, V.R ; Trivedi, H.L</creator><creatorcontrib>Shah, P.R ; Modi, P.R ; Kute, V.B ; Vanikar, A.V ; Patel, H.V ; Gumber, M.R ; Shah, V.R ; Trivedi, H.L</creatorcontrib><description>Abstract Background World Kidney Day (WKD) has become the most widely celebrated event associated with kidney disease in the world and the most successful effort to raise awareness among both the general public and government health officials about the dangers of kidney disease. We celebrated WKD 2010 in a unique way by performing 10 live-donor renal transplantations (RTx) on March 11, 2010. Patients and Methods We report a single-center experience on RTx vis-à-vis patient/graft survival, graft function in terms of serum creatinine (SCr) level, and rejection episodes in 10 live-donor RTx performed on WKD. Recipient diseases leading to end-stage renal disease (ESRD) were chronic glomerulonephritis (60%), benign nephrosclerosis (20%), and chronic interstitial nephritis (20%). Mean recipient age was 35 ± 8.7 years. Nine recipients were males. Mean donor age was 37 ± 8.7 years, Nine donors were females. Donors were spouse (n = 6), mother (n = 2), sister (n = 1), and extended family member (n = 1), with mean HLA match 1.8 ± 1.48. All patients received steroids, calcinueurin inhibitors, and mycophenolate mofetil/azathioprime for maintenance immunosuppression. Results During a mean follow-up time of 18 months, patient and graft survival rates were 90% and 90%, respectively, with a mean SCr level of 1.21 mg/dL; 20% had biopsy-proven acute rejection. One patient died due to infection after antirejection therapy. Conclusion RTx has acceptable graft and patient survival. RTx is the best cost-effective therapeutic modality for patients suffering from ESRD and should be encouraged in view of organ shortage on events such as WKD. To our knowledge, this is the first report from a developing country on 10 successful RTx on WKD.</description><identifier>ISSN: 0041-1345</identifier><identifier>EISSN: 1873-2623</identifier><identifier>DOI: 10.1016/j.transproceed.2011.11.029</identifier><identifier>PMID: 22310575</identifier><identifier>CODEN: TRPPA8</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>Adult ; Biological and medical sciences ; Biomarkers - blood ; Creatinine - blood ; Developing Countries ; Female ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; Global Health ; Graft Rejection - blood ; Graft Rejection - etiology ; Graft Rejection - mortality ; Graft Rejection - prevention & control ; Graft Survival ; Health Promotion ; Histocompatibility ; Histocompatibility Testing ; HLA Antigens - immunology ; Humans ; Immunosuppressive Agents - therapeutic use ; India ; Kidney Failure, Chronic - therapy ; Kidney Transplantation - adverse effects ; Kidney Transplantation - immunology ; Kidney Transplantation - mortality ; Living Donors ; Male ; Medical sciences ; Middle Aged ; Miscellaneous ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; Surgery ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the urinary system ; Time Factors ; Tissue, organ and graft immunology ; Treatment Outcome</subject><ispartof>Transplantation proceedings, 2012, Vol.44 (1), p.47-48</ispartof><rights>Elsevier Inc.</rights><rights>2012 Elsevier Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c464t-d11c72a135a75f1d0a620c8a59d928e68ab153e791edaed165726ade4f3aef363</citedby><cites>FETCH-LOGICAL-c464t-d11c72a135a75f1d0a620c8a59d928e68ab153e791edaed165726ade4f3aef363</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0041134511016265$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,776,780,785,786,3537,4010,4036,4037,23909,23910,25118,27900,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25919861$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22310575$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shah, P.R</creatorcontrib><creatorcontrib>Modi, P.R</creatorcontrib><creatorcontrib>Kute, V.B</creatorcontrib><creatorcontrib>Vanikar, A.V</creatorcontrib><creatorcontrib>Patel, H.V</creatorcontrib><creatorcontrib>Gumber, M.R</creatorcontrib><creatorcontrib>Shah, V.R</creatorcontrib><creatorcontrib>Trivedi, H.L</creatorcontrib><title>World Kidney Day 2010: Medical Aspects of 10 Live-Donor Renal Transplantations in a Single Center From a Developing Country</title><title>Transplantation proceedings</title><addtitle>Transplant Proc</addtitle><description>Abstract Background World Kidney Day (WKD) has become the most widely celebrated event associated with kidney disease in the world and the most successful effort to raise awareness among both the general public and government health officials about the dangers of kidney disease. We celebrated WKD 2010 in a unique way by performing 10 live-donor renal transplantations (RTx) on March 11, 2010. Patients and Methods We report a single-center experience on RTx vis-à-vis patient/graft survival, graft function in terms of serum creatinine (SCr) level, and rejection episodes in 10 live-donor RTx performed on WKD. Recipient diseases leading to end-stage renal disease (ESRD) were chronic glomerulonephritis (60%), benign nephrosclerosis (20%), and chronic interstitial nephritis (20%). Mean recipient age was 35 ± 8.7 years. Nine recipients were males. Mean donor age was 37 ± 8.7 years, Nine donors were females. Donors were spouse (n = 6), mother (n = 2), sister (n = 1), and extended family member (n = 1), with mean HLA match 1.8 ± 1.48. All patients received steroids, calcinueurin inhibitors, and mycophenolate mofetil/azathioprime for maintenance immunosuppression. Results During a mean follow-up time of 18 months, patient and graft survival rates were 90% and 90%, respectively, with a mean SCr level of 1.21 mg/dL; 20% had biopsy-proven acute rejection. One patient died due to infection after antirejection therapy. Conclusion RTx has acceptable graft and patient survival. RTx is the best cost-effective therapeutic modality for patients suffering from ESRD and should be encouraged in view of organ shortage on events such as WKD. To our knowledge, this is the first report from a developing country on 10 successful RTx on WKD.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Creatinine - blood</subject><subject>Developing Countries</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>Global Health</subject><subject>Graft Rejection - blood</subject><subject>Graft Rejection - etiology</subject><subject>Graft Rejection - mortality</subject><subject>Graft Rejection - prevention & control</subject><subject>Graft Survival</subject><subject>Health Promotion</subject><subject>Histocompatibility</subject><subject>Histocompatibility Testing</subject><subject>HLA Antigens - immunology</subject><subject>Humans</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>India</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Kidney Transplantation - adverse effects</subject><subject>Kidney Transplantation - immunology</subject><subject>Kidney Transplantation - mortality</subject><subject>Living Donors</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Miscellaneous</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><subject>Surgery</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the urinary system</subject><subject>Time Factors</subject><subject>Tissue, organ and graft immunology</subject><subject>Treatment Outcome</subject><issn>0041-1345</issn><issn>1873-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNklGLEzEQxxdRvHr6FSQI4tPWTLKb3b0H4Wg9FSuCd-JjyCWzkrpNesm2UPzyztoeik_CQEjmP_8Mv5mieAF8DhzU6_V8TCbkbYoW0c0FB5hTcNE9KGbQNrIUSsiHxYzzCkqQVX1WPMl5zekuKvm4OBNCAq-belb8_BbT4NhH7wIe2NIcGNnxC_YJnbdmYJd5i3bMLPYMOFv5PZbLGGJiXzBQ-uZ3I4MJoxl9DJn5wAy79uH7gGyBYcTErlLc0OMS9zjELaXYIu7CmA5Pi0e9GTI-O53nxdertzeL9-Xq87sPi8tVaStVjaUDsI0wIGvT1D04bpTgtjV15zrRomrNLdQSmw7QGXSg6kYo47DqpcFeKnlevDr6ErG7HeZRb3y2OFDbGHdZd4JLpWTTkvLiqLQp5pyw19vkNyYdNHA9sddr_Td7PbHXFMSeip-fvtndbih3X3oPmwQvTwKTiW1PRtbnP7q6g65VQLrlUYcEZe8x6Ww9BksjSTQM7aL_v37e_GNjBx-mqf7AA-Z13CUaYdags9BcX0_bMi0LTMZC1fIXgP69Rg</recordid><startdate>2012</startdate><enddate>2012</enddate><creator>Shah, P.R</creator><creator>Modi, P.R</creator><creator>Kute, V.B</creator><creator>Vanikar, A.V</creator><creator>Patel, H.V</creator><creator>Gumber, M.R</creator><creator>Shah, V.R</creator><creator>Trivedi, H.L</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2012</creationdate><title>World Kidney Day 2010: Medical Aspects of 10 Live-Donor Renal Transplantations in a Single Center From a Developing Country</title><author>Shah, P.R ; Modi, P.R ; Kute, V.B ; Vanikar, A.V ; Patel, H.V ; Gumber, M.R ; Shah, V.R ; Trivedi, H.L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c464t-d11c72a135a75f1d0a620c8a59d928e68ab153e791edaed165726ade4f3aef363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Creatinine - blood</topic><topic>Developing Countries</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>Global Health</topic><topic>Graft Rejection - blood</topic><topic>Graft Rejection - etiology</topic><topic>Graft Rejection - mortality</topic><topic>Graft Rejection - prevention & control</topic><topic>Graft Survival</topic><topic>Health Promotion</topic><topic>Histocompatibility</topic><topic>Histocompatibility Testing</topic><topic>HLA Antigens - immunology</topic><topic>Humans</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>India</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Kidney Transplantation - adverse effects</topic><topic>Kidney Transplantation - immunology</topic><topic>Kidney Transplantation - mortality</topic><topic>Living Donors</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Miscellaneous</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><topic>Surgery</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the urinary system</topic><topic>Time Factors</topic><topic>Tissue, organ and graft immunology</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shah, P.R</creatorcontrib><creatorcontrib>Modi, P.R</creatorcontrib><creatorcontrib>Kute, V.B</creatorcontrib><creatorcontrib>Vanikar, A.V</creatorcontrib><creatorcontrib>Patel, H.V</creatorcontrib><creatorcontrib>Gumber, M.R</creatorcontrib><creatorcontrib>Shah, V.R</creatorcontrib><creatorcontrib>Trivedi, H.L</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shah, P.R</au><au>Modi, P.R</au><au>Kute, V.B</au><au>Vanikar, A.V</au><au>Patel, H.V</au><au>Gumber, M.R</au><au>Shah, V.R</au><au>Trivedi, H.L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>World Kidney Day 2010: Medical Aspects of 10 Live-Donor Renal Transplantations in a Single Center From a Developing Country</atitle><jtitle>Transplantation proceedings</jtitle><addtitle>Transplant Proc</addtitle><date>2012</date><risdate>2012</risdate><volume>44</volume><issue>1</issue><spage>47</spage><epage>48</epage><pages>47-48</pages><issn>0041-1345</issn><eissn>1873-2623</eissn><coden>TRPPA8</coden><abstract>Abstract Background World Kidney Day (WKD) has become the most widely celebrated event associated with kidney disease in the world and the most successful effort to raise awareness among both the general public and government health officials about the dangers of kidney disease. We celebrated WKD 2010 in a unique way by performing 10 live-donor renal transplantations (RTx) on March 11, 2010. Patients and Methods We report a single-center experience on RTx vis-à-vis patient/graft survival, graft function in terms of serum creatinine (SCr) level, and rejection episodes in 10 live-donor RTx performed on WKD. Recipient diseases leading to end-stage renal disease (ESRD) were chronic glomerulonephritis (60%), benign nephrosclerosis (20%), and chronic interstitial nephritis (20%). Mean recipient age was 35 ± 8.7 years. Nine recipients were males. Mean donor age was 37 ± 8.7 years, Nine donors were females. Donors were spouse (n = 6), mother (n = 2), sister (n = 1), and extended family member (n = 1), with mean HLA match 1.8 ± 1.48. All patients received steroids, calcinueurin inhibitors, and mycophenolate mofetil/azathioprime for maintenance immunosuppression. Results During a mean follow-up time of 18 months, patient and graft survival rates were 90% and 90%, respectively, with a mean SCr level of 1.21 mg/dL; 20% had biopsy-proven acute rejection. One patient died due to infection after antirejection therapy. Conclusion RTx has acceptable graft and patient survival. RTx is the best cost-effective therapeutic modality for patients suffering from ESRD and should be encouraged in view of organ shortage on events such as WKD. To our knowledge, this is the first report from a developing country on 10 successful RTx on WKD.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>22310575</pmid><doi>10.1016/j.transproceed.2011.11.029</doi><tpages>2</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0041-1345 |
ispartof | Transplantation proceedings, 2012, Vol.44 (1), p.47-48 |
issn | 0041-1345 1873-2623 |
language | eng |
recordid | cdi_proquest_miscellaneous_920366378 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adult Biological and medical sciences Biomarkers - blood Creatinine - blood Developing Countries Female Fundamental and applied biological sciences. Psychology Fundamental immunology Global Health Graft Rejection - blood Graft Rejection - etiology Graft Rejection - mortality Graft Rejection - prevention & control Graft Survival Health Promotion Histocompatibility Histocompatibility Testing HLA Antigens - immunology Humans Immunosuppressive Agents - therapeutic use India Kidney Failure, Chronic - therapy Kidney Transplantation - adverse effects Kidney Transplantation - immunology Kidney Transplantation - mortality Living Donors Male Medical sciences Middle Aged Miscellaneous Public health. Hygiene Public health. Hygiene-occupational medicine Surgery Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the urinary system Time Factors Tissue, organ and graft immunology Treatment Outcome |
title | World Kidney Day 2010: Medical Aspects of 10 Live-Donor Renal Transplantations in a Single Center From a Developing Country |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T00%3A06%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=World%20Kidney%20Day%202010:%20Medical%20Aspects%20of%2010%20Live-Donor%20Renal%20Transplantations%20in%20a%20Single%20Center%20From%20a%20Developing%20Country&rft.jtitle=Transplantation%20proceedings&rft.au=Shah,%20P.R&rft.date=2012&rft.volume=44&rft.issue=1&rft.spage=47&rft.epage=48&rft.pages=47-48&rft.issn=0041-1345&rft.eissn=1873-2623&rft.coden=TRPPA8&rft_id=info:doi/10.1016/j.transproceed.2011.11.029&rft_dat=%3Cproquest_cross%3E920366378%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=920366378&rft_id=info:pmid/22310575&rft_els_id=1_s2_0_S0041134511016265&rfr_iscdi=true |